Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

7 Penny Stocks to Buy Before They Take Off

By Josh Enomoto, InvestorPlace Contributor

Typically, penny stocks are nothing more than legalized gambling. However, these seven high-risk, high-reward names covering various industries offer compelling narratives that just might pan out.

El Paso Dominates the News, but the Trade War Truly Hurts Walmart Stock

By Josh Enomoto, InvestorPlace Contributor

Unquestionably, the unspeakable crime at an El Paso Walmart casts a dark cloud on WMT stock. But from a purely investment point-of-view, the trade war is the biggest threat to its market value.

Qualcomm Stock Benefits from Wall Street’s Patience

By Josh Enomoto, InvestorPlace Contributor

QCOM stock forwarded a disappointing earnings report, but Qualcomm has found significant market support due to its critical importance.

3 Reasons to Play the Patient Game with Facebook Stock

By Josh Enomoto, InvestorPlace Contributor

The panic over the severity of the U.S.-China trade war has dropped many investments, including Facebook stock. However, the social media giant enjoys multiple fundamental catalysts if you’re willing to play the long game.

Risk-Takers Have a Reasonable Shot with BMY Stock

By Josh Enomoto, InvestorPlace Contributor

Political pressures regarding drug pricing and Bristol-Myers’ disappointing clinical trails have contributed to a disappointing performance for BMY stock. Still, much of this bearishness could be priced in already.

Load More